Xylopropamine
| Xylopropamine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Xylopropamine is a stimulant drug that was developed in the mid-20th century. It is chemically related to amphetamines and has been studied for its potential effects on the central nervous system.
Chemical Structure[edit]
Xylopropamine is a phenethylamine derivative, characterized by its unique chemical structure. The compound consists of a phenyl ring with a propylamine side chain, which is similar to other compounds in the amphetamine class. The presence of a xylo group distinguishes it from other related stimulants.
Pharmacology[edit]
Xylopropamine acts primarily as a central nervous system stimulant. It is believed to increase the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. This action results in increased alertness, energy, and concentration, similar to the effects of other stimulants like methylphenidate and amphetamine.
Medical Use[edit]
While Xylopropamine was initially investigated for potential therapeutic uses, such as treating attention deficit hyperactivity disorder (ADHD) and narcolepsy, it has not been widely adopted in clinical practice. The development of other more effective and safer stimulant medications has limited its use.
Side Effects[edit]
As with other stimulants, Xylopropamine can cause a range of side effects. Common side effects include increased heart rate, elevated blood pressure, insomnia, and anxiety. Long-term use or abuse of stimulants can lead to more serious health issues, including cardiovascular problems and psychological dependence.
Legal Status[edit]
The legal status of Xylopropamine varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and addiction. It is important to consult local regulations to determine its legal status in a specific area.
Related Compounds[edit]
Xylopropamine is related to several other stimulant compounds, including:
Related pages[edit]
-
Xylopropamine
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian